Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer.
Publication
, Preprint
Lim, BJW; Liu, M; Wang, L; Kong, SLY; Yin, T; Yan, C; Xiang, K; Cao, C; Wu, H; Mihai, A; Tay, FP-L; Wang, E; Jiang, Q; Ma, Z; Tan, L ...
February 2, 2025
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Lim, B. J. W., Liu, M., Wang, L., Kong, S. L. Y., Yin, T., Yan, C., … Li, Q.-J. (2025). Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer. https://doi.org/10.1101/2025.01.29.635356
Lim, Bryan Jian Wei, Mingyong Liu, Liuyang Wang, Sharleen Li Ying Kong, Tao Yin, Chengsong Yan, Kun Xiang, et al. “Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer.,” February 2, 2025. https://doi.org/10.1101/2025.01.29.635356.
Lim BJW, Liu M, Wang L, Kong SLY, Yin T, Yan C, et al. Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer. 2025.
Lim, Bryan Jian Wei, et al. Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer. 2 Feb. 2025. Pubmed, doi:10.1101/2025.01.29.635356.
Lim BJW, Liu M, Wang L, Kong SLY, Yin T, Yan C, Xiang K, Cao C, Wu H, Mihai A, Tay FP-L, Wang E, Jiang Q, Ma Z, Tan L, Chia RN, Qin D, Pan CC, Wang X-F, Li Q-J. Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer. 2025.